Roc Rock Biotechnology (Shenzhen) Co., LTD., chairman, Liaoning Xingliao Talents (leading talents), Liaoning Province outstanding scientific and technological workers, Shenyang high-level talents. Research interests: Cell drugs, with more than 15 years of research and industry background in cell biology. He has published more than 20 articles in Nature Cell Biology, Nature Communications Biology, Clinical Chemistry, Cell Research, Heliyon, etc. He has worked at the European Molecular Biology Laboratory, the University of Cologne Medical School, the Marx-Delbruck Center for Molecular Medicine and the Karolinska Institute in Sweden. He has presided over 9 domestic and international funds, including the National Natural Science Foundation, the National Key Research and Development Plan, and the German Science Foundation, with a total fund of 40 million yuan. It has authorized 30 patents. Completed 4 product R&D and transformation projects, and successfully promoted 2 stem cell drugs into IIT trials and progressed smoothly. He has won the first prize of Beijing Science and Technology and the second prize of Chinese Medical Association, and two scientific research achievements won the most popular Chinese papers of 2021 Cell magazine.